S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
ABCL · AbCellera Biologics Inc. Common Shares
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Abcellera Biologics Inc (ABCL)
NASDAQ NMS - GLOBAL MARKET
Life Sciences Tools & Services
$12.24
+0.54
(+4.62%)
● At close: October 21 at 4:00:00 PM EDT
$12.03
-0.21
(-1.72%)
Overnight:
1:55:38 AM EDT
DAY'S RANGE
$12.24
$11.62
$12.37
52-WEEK RANGE
$12.24
$2.75
$15.02
What's happening
- ABCL is up 4.62% today, trading at $12.24. — Live quote
- Volume today (198,201) is well below its 3-month average of 6,760,080. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.18 actual vs. $-0.15 estimated (-23.5%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 12
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (17 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ABCL
+248.83%
vs S&P 500
+236.43%
1-YEAR RETURN
ABCL
+113.42%
vs S&P 500
+98.05%
6-MONTH RETURN
ABCL
+209.07%
3-MONTH RETURN
ABCL
+105.69%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.18
Est. $-0.15
MISS -23.5%
2026-04-26 (Q1 2026)
$-0.14
Est. $-0.20
BEAT +29.9%
2026-01-26 (Q4 2025)
$-0.03
Est. $-0.18
BEAT +83.1%
2025-10-26 (Q3 2025)
$-0.19
Est. $-0.17
MISS -10.4%
Valuation Measures & Ratios
Enterprise Value4$3.85B
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)59.94
Price / Book72.68
EV4 / Revenue58.12
EV4 / EBITDA15.74
Profit Margin-248.83%
Operating Margin-340.25%
Return on Equity (ROE8)-17.49%
Return on Assets (ROA9)-12.36%
Avg Volume (3M)6,760,080
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $2.42B | $1.08B | $1.51B | $989.7M | $675.2M |
| P/E | -12.68 | -5.97 | -8.01 | -5.88 | -3.87 |
| Price/Sales | 62.90 | 27.92 | 41.07 | 28.16 | 24.10 |
| Price/Book | 2.70 | 1.15 | 1.57 | 0.98 | 0.66 |
| EV/Revenue | 59.78 | 25.93 | 38.81 | 25.53 | 18.41 |
| ROE | -21.25% | -19.26% | -19.56% | -16.72% | -17.04% |
| ROA | -14.56% | -13.82% | -13.91% | -12.01% | -12.96% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short32,498,416
Change from Prior Settlement-4.22%
% of Float—
Days to Cover (Short Ratio)5.98
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +113.4%. Finnhub market metrics ↗
- Latest SEC filing is Form 4, filed 2026-08-24; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -76.3% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -248.8%. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ABCL
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0M | $8.3M | $9.0M | $17.1M | $4.2M | $6.5M | $7.3M | $10.0M |
| Operating income | -$62.8M | -$57.5M | -$76.3M | -$49.6M | -$62.7M | -$93.7M | -$93.5M | -$54.9M |
| Net income | -$55.4M | -$43.2M | -$57.1M | -$34.7M | -$45.6M | -$51.1M | -$36.9M | -$40.6M |
| EPS (diluted) | $-0.18 | $-0.14 | $-0.19 | $-0.12 | $-0.15 | $-0.17 | $-0.13 | $-0.14 |
| EPS (basic) | $-0.18 | $-0.14 | $-0.19 | $-0.12 | $-0.15 | $-0.17 | $-0.13 | $-0.14 |
| Operating margin | -$1.6K | -$692 | -$852 | -$290 | -$1.5K | -$1.4K | -$1.3K | -$551 |
| Net margin | -$1.4K | -$519 | -$638 | -$203 | -$1.1K | -$785 | -$504 | -$408 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.31B | $1.31B | $1.36B | $1.36B | $1.40B | $1.34B | $1.36B | $1.39B |
| Total liabilities | $411.6M | $369.0M | $390.0M | $392.0M | $395.0M | $321.2M | $304.5M | $314.7M |
| Stockholders' equity | $896.0M | $938.1M | $966.9M | $964.0M | $1.01B | $1.02B | $1.06B | $1.08B |
| Total current assets | $679.2M | $664.6M | $728.2M | $695.1M | $742.1M | $765.0M | $751.4M | $742.9M |
| Total current liabilities | $53.2M | $47.3M | $64.3M | $68.8M | $67.0M | $75.4M | $76.6M | $79.6M |
| Cash & equivalents | $120.1M | $77.1M | $128.5M | $83.2M | $92.4M | $159.3M | $156.3M | $126.6M |
| Accounts receivable | $38.4M | $39.2M | $39.4M | $71.2M | $70.0M | $63.6M | $32.0M | — |
| Inventory | $7.6M | $7.9M | $6.3M | — | — | — | $0 | — |
| Other current assets | $95.5M | $98.1M | $111.1M | $133.0M | $116.8M | $94.7M | $67.1M | $43.4M |
| Property, plant & equipment | — | — | — | — | — | — | — | — |
| Goodwill | $47.8M | $47.8M | $47.8M | $47.8M | $47.8M | $47.8M | $47.8M | $47.8M |
| Intangible assets | $36.5M | $37.5M | $38.4M | $39.3M | $40.3M | $41.2M | $42.1M | $52.6M |
| Other non-current assets | $62.1M | $69.1M | $51.9M | $53.1M | $57.5M | $61.6M | $96.5M | $134.2M |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | $20.7M | $7.7M | $13.5M | $15.7M | $16.9M | $18.8M | $13.5M | $5.6M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $9.7M | $11.3M | $10.4M | $1.4M | $1.6M | $1.6M | $7.2M | $1.5M |
| Common stock & paid-in capital | $821.2M | $816.5M | $802.3M | $794.5M | $791.7M | $790.1M | $777.2M | $772.8M |
| Retained earnings | -$128.1M | -$72.6M | -$29.5M | -$20.5M | $36.6M | $71.3M | $116.9M | $151.1M |
| Accumulated other comprehensive income (loss) | -$3.2M | -$2.4M | -$4.2M | -$2.7M | -$2.7M | -$7.0M | -$4.4M | -$1.2M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $25.9M | -$33.5M | -$34.7M | -$52.6M | -$32.4M | -$11.6M | -$8.0M | -$28.9M |
| Investing cash flow | $11.3M | -$25.1M | $75.1M | $36.5M | -$31.8M | $7.9M | $35.7M | $3.7M |
| Financing cash flow | $6.4M | $7.2M | $4.1M | $7.4M | -$3.4M | $6.0M | $4.1M | $3.1M |
| Free cash flow | $23.8M | -$37.4M | -$44.6M | -$61.5M | -$45.8M | -$22.2M | -$23.6M | -$47.4M |
| Capital expenditures | $2.1M | $3.8M | $9.8M | $8.9M | $13.4M | $10.6M | $15.6M | $18.5M |
| Depreciation & amortization | $7.0M | $6.8M | — | — | $5.5M | $5.3M | — | — |
| Share-based compensation | $12.3M | $12.0M | $12.9M | $13.9M | $14.2M | $14.8M | $15.2M | $17.2M |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Purchases of investments | $141.9M | $166.3M | $111.3M | $33.2M | $126.6M | $165.0M | $152.8M | $186.2M |
| Debt issued | — | — | — | — | — | — | — | $3.1M |
| Debt repaid | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $75.1M | $28.8M | $38.0M | $485.4M | $375.2M |
| Operating income | -$217.1M | -$314.8M | -$237.2M | $216.5M | $204.4M |
| Net income | -$146.4M | -$162.9M | -$146.4M | $158.5M | $153.5M |
| EPS (diluted) | $-0.49 | $-0.55 | $-0.51 | $0.50 | $0.48 |
| EPS (basic) | $-0.49 | $-0.55 | $-0.51 | $0.56 | $0.56 |
| Operating margin | -$289 | -$1.1K | -$624 | $45 | $54 |
| Net margin | -$195 | -$565 | -$385 | $33 | $41 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.36B | $1.36B | $1.49B | $1.54B | $1.32B |
| Total liabilities | $390.0M | $304.5M | $335.8M | $307.6M | $292.8M |
| Stockholders' equity | $966.9M | $1.06B | $1.15B | $1.23B | $1.03B |
| Total current assets | $728.2M | $751.4M | $872.0M | $1.03B | $929.8M |
| Total current liabilities | $64.3M | $76.6M | $119.0M | $118.3M | $120.7M |
| Cash & equivalents | $128.5M | $156.3M | $133.3M | $386.5M | $476.1M |
| Accounts receivable | $39.4M | $32.0M | $0 | — | — |
| Inventory | $6.3M | $0 | — | — | — |
| Other current assets | $111.1M | $67.1M | $55.8M | $75.4M | $21.2M |
| Property, plant & equipment | — | — | — | $217.3M | $111.6M |
| Goodwill | $47.8M | $47.8M | $47.8M | $47.8M | $47.8M |
| Intangible assets | $38.4M | $42.1M | $120.4M | $131.5M | $148.4M |
| Other non-current assets | $51.9M | $96.5M | $94.2M | $46.3M | $30.6M |
| Accrued liabilities | — | — | — | $0 | $0 |
| Deferred revenue (current) | $13.5M | $13.5M | $19.0M | $21.6M | $7.5M |
| Other non-current liabilities | $4.8M | $7.2M | $5.9M | $3.1M | $1.7M |
| Common stock & paid-in capital | $802.3M | $777.2M | $753.2M | $734.4M | $722.4M |
| Retained earnings | -$29.5M | $116.9M | $279.8M | $426.2M | $267.7M |
| Accumulated other comprehensive income (loss) | -$4.2M | -$4.4M | -$1.7M | -$1.4M | $280.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$131.3M | -$108.6M | -$43.9M | $277.4M | $244.6M |
| Investing cash flow | $87.8M | $121.4M | -$221.1M | -$352.6M | -$332.2M |
| Financing cash flow | $14.1M | $12.8M | $10.4M | -$1.6M | -$3.9M |
| Free cash flow | -$174.1M | -$187.0M | -$120.8M | $206.7M | $186.1M |
| Capital expenditures | $42.8M | $78.4M | $76.9M | $70.7M | $58.5M |
| Share-based compensation | $55.8M | $67.6M | $64.2M | $49.5M | $30.6M |
| Deferred income taxes | — | — | $2.0M | -$2.1M | -$2.0M |
| Purchases of investments | $436.0M | $765.1M | $1.02B | $764.0M | $274.7M |
| Debt issued | — | — | — | — | $872.0K |
| Debt repaid | — | — | — | — | $1.8M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ABCL as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers35.6%
Shares Outstanding305,557,294
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 33,012,138 | $259.1M | 10.80% | +9.0% | 2026-08-14 |
| Capital World Investors | 13,588,349 | $106.7M | 4.45% | +1.7% | 2026-08-07 |
| TWO SIGMA INVESTMENTS, LP | 10,437,431 | $81.9M | 3.42% | -1.2% | 2026-08-07 |
| TD Waterhouse Canada Inc. | 9,568,149 | $72.6M | 3.13% | +0.0% | 2026-07-27 |
| Bank Of America Corp /De/ | 6,141,539 | $48.2M | 2.01% | +104.7% | 2026-08-14 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 4,317,206 | $33.9M | 1.41% | -43.0% | 2026-08-13 |
| ArrowMark Colorado Holdings LLC | 4,105,095 | $32.2M | 1.34% | +0.0% | 2026-08-13 |
| BlackRock, Inc. | 3,805,309 | $29.9M | 1.25% | -5.8% | 2026-08-07 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,864,729 | $22.5M | 0.94% | -28.8% | 2026-08-14 |
| TUDOR INVESTMENT CORP ET AL | 2,063,191 | $16.2M | 0.68% | -9.3% | 2026-08-14 |
| MARSHALL WACE, LLP | 1,902,191 | $14.9M | 0.62% | +428.9% | 2026-08-13 |
| UBS Group AG | 1,870,633 | $14.7M | 0.61% | -55.6% | 2026-08-13 |
| Morgan Stanley | 1,669,014 | $13.1M | 0.55% | -25.0% | 2026-08-11 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,587,870 | $12.5K | 0.52% | +0.0% | 2026-08-14 |
| CITADEL ADVISORS LLC | 1,586,512 | $12.5M | 0.52% | +16.6% | 2026-08-14 |
| NATIONAL BANK OF CANADA /FI/ | 1,233,014 | $9.7M | 0.40% | +88415.0% | 2026-08-07 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,039,927 | $8.2M | 0.34% | +0.0% | 2026-08-13 |
| RENAISSANCE TECHNOLOGIES LLC | 990,929 | $7.8M | 0.32% | -34.4% | 2026-08-13 |
| Counterpoint Mutual Funds LLC | 971,643 | $7.6M | 0.32% | +0.0% | 2026-07-20 |
| State Street Corp | 731,362 | $5.7M | 0.24% | +0.2% | 2026-08-07 |
| HRT FINANCIAL LP | 705,506 | $5.5K | 0.23% | -42.9% | 2026-08-14 |
| DnB Asset Management AS | 677,479 | $5.3M | 0.22% | +0.0% | 2026-08-11 |
| Guardian Partners Inc. | 595,998 | $4.7M | 0.20% | -66.6% | 2026-07-29 |
| Intellectus Partners, LLC | 551,583 | $4.3M | 0.18% | +1.0% | 2026-08-12 |
| Alyeska Investment Group, L.P. | 526,577 | $4.1M | 0.17% | -79.7% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-11-26 to 2026-08-24
Recent transactions
- Insiders have net bought 167,200 shares over the last 182 days, across 5 purchases and 0 sales.
- Most recent: Hayden Michael R (Director) — Open market purchase of 53,613 shares on 2026-08-24.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)167,200 sh(5 txns)
Sales (open market)0 sh(0 txns)
Net Shares+167,200
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Hayden Michael R | Director | Open market purchase | 2026-08-24 | 53,613 |
| Montalbano John S. | Director | Open market purchase | 2026-08-18 | 10,000 |
| Booth Andrew | Chief Financial Officer | Open market purchase | 2026-08-14 | 37,200 |
| Thermopylae Holdings Ltd. | 10% owner | Open market purchase | 2026-02-27 | 38,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-24 | Hayden Michael R | Director | Open market purchase | 53,613 | $10.64 |
| 2026-08-18 | Montalbano John S. | Director | Open market purchase | 10,000 | $11.03 |
| 2026-08-14 | Booth Andrew | Chief Financial Officer | Open market purchase | 37,200 | $10.32 |
| 2026-08-12 | Hayden Michael R | Director | Open market purchase | 46,387 | $10.37 |
| 2026-08-11 | Hayden Michael R | Director | Gift | 50,000 | $0.00 |
| 2026-06-03 | Booth Andrew | Chief Financial Officer | Option exercise | 250,000 | $0.19 |
| 2026-05-14 | Montalbano John S. | Director | Open market purchase | 20,000 | $4.77 |
| 2026-02-27 | Thermopylae Holdings Ltd. | 10% owner | Open market purchase | 38,000 | $3.44 |
| 2026-02-27 | Booth Andrew | Chief Financial Officer | Open market purchase | 42,600 | $3.42 |
| 2026-02-26 | Thermopylae Holdings Ltd. | 10% owner | Open market purchase | 177,457 | $3.27 |
| 2025-12-18 | Thermopylae Holdings Ltd. | 10% owner | Gift | 225,000 | $0.00 |
| 2025-11-26 | Montalbano John S. | Director | Open market purchase | 50,000 | $3.57 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 02:12 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-24 | 4 | 2026-08-24 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-12 | View on SEC.gov → |
| 2026-08-13 | 8-K | 2026-08-12 | View on SEC.gov → |
| 2026-08-13 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-08-07 | 8-K | 2026-08-07 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-29 | 8-K | 2026-07-29 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
Recent news
Headlines about ABCL (AbCellera Biologics Inc. Common Shares). Links open the publisher — we don’t host full articles.
-
ABCL Nov 2026 9.000 call (ABCL261120C00009000) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
ABCL270416P00016000 Interactive Stock Chart | ABCL Apr 2027 16.000 put Stock
Yahoo! Finance Canada · 2026-10-18 -
ABCL Apr 2027 16.000 put (ABCL270416P00016000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-18 -
Avoiding Lag: Real-Time Signals in (ABCL) Movement
Stock Traders Daily · 2026-10-18 -
ABCL Nov 2026 28.000 call (ABCL261120C00028000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-17 -
ABCL Nov 2026 6.000 call (ABCL261120C00006000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-17 -
ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL)
ChartMill · 2026-10-16 -
AbCellera Biologics (ABCL) Institutional Ownership 2026
MarketBeat · 2026-10-16
No headlines in this category right now — try “All”.